Hajra Zafar
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 17
- Supramolecular Self-Assembly in Materials 5
- Molecular Medicine top 5%
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems 5
- Drug Solubulity and Delivery Systems 4
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 13
- Graphene and Nanomaterials Applications 4
-
- RNA Interference and Gene Delivery 5
-
- Pharmacological Effects of Natural Compounds 4
In The Last Decade
Hajra Zafar
53 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 101
- Biomaterials 491
- Molecular Medicine 140
- Pharmaceutical Science 141
- Biomedical Engineering 449
- Molecular Biology 406
Countries citing papers authored by Hajra Zafar
This map shows the geographic impact of Hajra Zafar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajra Zafar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajra Zafar more than expected).
Fields of papers citing papers by Hajra Zafar
This network shows the impact of papers produced by Hajra Zafar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajra Zafar. The network helps show where Hajra Zafar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hajra Zafar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 2 | |
| 6 | 2024 | 26 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 55 | |
| 15 | 2022 | 22 | |
| 16 | 2022 | 72 | |
| 17 | 2022 | 49 | |
| 18 | 2022 | 18 | |
| 19 | 2022 | 11 | |
| 20 | 2019 | 163 |
About Hajra Zafar
Hajra Zafar is a scholar working on Biomaterials, Pharmaceutical Science, Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 55 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (17 papers), Nanoplatforms for cancer theranostics (13 papers), RNA Interference and Gene Delivery (5 papers), Advanced Drug Delivery Systems (5 papers), Supramolecular Self-Assembly in Materials (5 papers), Drug Solubulity and Delivery Systems (4 papers), Pharmacological Effects of Natural Compounds (4 papers) and Graphene and Nanomaterials Applications (4 papers). The work is most often cited by research in Biomaterials (491 citations), Molecular Medicine (140 citations), Pharmaceutical Science (141 citations), Biomedical Engineering (449 citations) and Molecular Biology (406 citations). Hajra Zafar has collaborated with scholars based in China, Pakistan and Portugal. Frequent co-authors include Faisal Raza, Liang Ge, Ana Cláudia Paiva‐Santos, Ying Zhu, Xinru You, Khan Asifullah, Mingfeng Qiu, Jing Su, Zul Kamal and Weien Yuan. Their work appears in journals such as Frontiers in Pharmacology, Materials Advances, Pharmaceutics, Colloids and Surfaces B Biointerfaces and Current Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.